Screener
Outset Medical, Inc. OM Q3 2026 earnings
Reported November 4, 2026 · After market close
Revenue$33.6MBeat by $2.2M
EPS-$0.68Beat by $0.01
Revenue estimate$31.4M
EPS estimate-$0.69
“Third-quarter results demonstrated continued progress against our strategic priorities and solid sales execution across both capital and recurring revenue. Consistently strong customer satisfaction and retention are expanding adoption of Tablo across our existing customer base and fueling new insourced dialysis partnerships with leading health systems. Advancing our mission to help providers nationwide improve the cost, complexity and clinical outcomes of dialysis continues to position Outset well for sustained long-term growth and value creation.”
Next report
Feb 10, 2027 (in 3 months)Revenue estimate$34.4M
EPS estimate-$0.64
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Outset Medical, Inc. report Q3 2026 earnings?
- Outset Medical, Inc. (OM) reported Q3 2026 earnings on November 4, 2026 after market close.
- What were Outset Medical, Inc.'s Q3 2026 revenue and EPS?
- Outset Medical, Inc. reported revenue of $33.6M and eps of $-0.68 for Q3 2026.
- Did Outset Medical, Inc. beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $31.4M by $2.2M. EPS beat the consensus estimate of $-0.69 by $0.01.
- How did Outset Medical, Inc.'s Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 14.2% from $29.4M a year earlier and eps grew 1.4% from $-0.69.
- Where can I find Outset Medical, Inc.'s Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-447293) and the 10-Q periodic report (0001193125-26-447683) directly on SEC EDGAR. The filing index links above go to sec.gov.
